135 related articles for article (PubMed ID: 11431100)
1. Effect of bile acids on formation of azoxymethane-induced aberrant crypt foci in colostomized F344 rat colon.
Lin CX; Umemoto A; Seraj MJ; Mimura S; Monden Y
Cancer Lett; 2001 Aug; 169(2):121-6. PubMed ID: 11431100
[TBL] [Abstract][Full Text] [Related]
2. Effect of ursodeoxycholic acid on azoxymethane-induced aberrant crypt foci formation in rat colon: in vitro potential role of intracellular Ca2+.
Momen MA; Monden Y; Houchi H; Umemoto A
J Med Invest; 2002 Feb; 49(1-2):67-73. PubMed ID: 11901763
[TBL] [Abstract][Full Text] [Related]
3. Enrichment of the more hydrophilic bile acid ursodeoxycholic acid in the fecal water-soluble fraction after feeding to rats with colon polyps.
Batta AK; Salen G; Holubec H; Brasitus TA; Alberts D; Earnest DL
Cancer Res; 1998 Apr; 58(8):1684-7. PubMed ID: 9563483
[TBL] [Abstract][Full Text] [Related]
4. Effects of dietary bile acids on formation of azoxymethane-induced aberrant crypt foci in F344 rats.
Seraj MJ; Umemoto A; Kajikawa A; Mimura S; Kinouchi T; Ohnishi Y; Monden Y
Cancer Lett; 1997 May; 115(1):97-103. PubMed ID: 9097984
[TBL] [Abstract][Full Text] [Related]
5. Effects of bile acids on 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-induced aberrant crypt foci and DNA adduct formation in the rat colon.
Ueyama Y; Monden Y; He XB; Lin CX; Momen MA; Mimura S; Umemoto A
J Exp Clin Cancer Res; 2002 Dec; 21(4):577-83. PubMed ID: 12636105
[TBL] [Abstract][Full Text] [Related]
6. Ursodeoxycholic acid inhibits the initiation and postinitiation phases of azoxymethane-induced colonic tumor development.
Wali RK; Stoiber D; Nguyen L; Hart J; Sitrin MD; Brasitus T; Bissonnette M
Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1316-21. PubMed ID: 12433708
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effects of ursodeoxycholic acid on N-methylnitrosourea-induced colon carcinogenesis and colonic mucosal telomerase activity in F344 rats.
Narisawa T; Fukaura Y; Terada K; Sekiguchi H
J Exp Clin Cancer Res; 1999 Jun; 18(2):259-66. PubMed ID: 10464717
[TBL] [Abstract][Full Text] [Related]
8. Comparative effects of secondary bile acids, deoxycholic and lithocholic acids, on aberrant crypt foci growth in the postinitiation phases of colon carcinogenesis.
Baijal PK; Fitzpatrick DW; Bird RP
Nutr Cancer; 1998; 31(2):81-9. PubMed ID: 9770718
[TBL] [Abstract][Full Text] [Related]
9. Biliary bile acids in primary biliary cirrhosis: effect of ursodeoxycholic acid.
Combes B; Carithers RL; Maddrey WC; Munoz S; Garcia-Tsao G; Bonner GF; Boyer JL; Luketic VA; Shiffman ML; Peters MG; White H; Zetterman RK; Risser R; Rossi SS; Hofmann AF
Hepatology; 1999 Jun; 29(6):1649-54. PubMed ID: 10347103
[TBL] [Abstract][Full Text] [Related]
10. Modulation of colonic xenobiotic metabolizing enzymes by feeding bile acids: comparative effects of cholic, deoxycholic, lithocholic and ursodeoxycholic acids.
Baijal PK; Fitzpatrick DW; Bird RP
Food Chem Toxicol; 1998 Jul; 36(7):601-7. PubMed ID: 9687967
[TBL] [Abstract][Full Text] [Related]
11. Effect of dietary deoxycholic acid and cholesterol on fecal steroid concentration and its impact on the colonic crypt cell proliferation in azoxymethane-treated rats.
Hori T; Matsumoto K; Sakaitani Y; Sato M; Morotomi M
Cancer Lett; 1998 Feb; 124(1):79-84. PubMed ID: 9500195
[TBL] [Abstract][Full Text] [Related]
12. Ursodeoxycholic acid and F(6)-D(3) inhibit aberrant crypt proliferation in the rat azoxymethane model of colon cancer: roles of cyclin D1 and E-cadherin.
Wali RK; Khare S; Tretiakova M; Cohen G; Nguyen L; Hart J; Wang J; Wen M; Ramaswamy A; Joseph L; Sitrin M; Brasitus T; Bissonnette M
Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1653-62. PubMed ID: 12496057
[TBL] [Abstract][Full Text] [Related]
13. Effects of repeated boluses of sucrose on proliferation and on AOM-induced aberrant crypt foci in rat colon.
Luceri C; Caderni G; Lancioni L; Aiolli S; Dolara P; Mastrandrea V; Scardazza F; Morozzi G
Nutr Cancer; 1996; 25(2):187-96. PubMed ID: 8710688
[TBL] [Abstract][Full Text] [Related]
14. Polyethylene-glycol, a potent suppressor of azoxymethane-induced colonic aberrant crypt foci in rats.
Corpet DE; Parnaud G
Carcinogenesis; 1999 May; 20(5):915-8. PubMed ID: 10334212
[TBL] [Abstract][Full Text] [Related]
15. Tumor-enhancing effects of cholic acid are exerted on the early stages of colon carcinogenesis via induction of aberrant crypt foci with an enhanced growth phenotype.
Baijal PK; Clow EP; Fitzpatrick DW; Bird RP
Can J Physiol Pharmacol; 1998 Dec; 76(12):1095-102. PubMed ID: 10326831
[TBL] [Abstract][Full Text] [Related]
16. Inhibition by dietary curcumin of azoxymethane-induced ornithine decarboxylase, tyrosine protein kinase, arachidonic acid metabolism and aberrant crypt foci formation in the rat colon.
Rao CV; Simi B; Reddy BS
Carcinogenesis; 1993 Nov; 14(11):2219-25. PubMed ID: 8242846
[TBL] [Abstract][Full Text] [Related]
17. Ability of aberrant crypt foci characteristics to predict colonic tumor incidence in rats fed cholic acid.
Magnuson BA; Carr I; Bird RP
Cancer Res; 1993 Oct; 53(19):4499-504. PubMed ID: 8402621
[TBL] [Abstract][Full Text] [Related]
18. Effects of a high-fat diet on azoxymethane-induced aberrant crypt foci and fecal biochemistry and microbial activity in rats.
Morotomi M; Sakaitani Y; Satou M; Takahashi T; Takagi A; Onoue M
Nutr Cancer; 1997; 27(1):84-91. PubMed ID: 8970188
[TBL] [Abstract][Full Text] [Related]
19. Diosgenin, a steroid saponin of Trigonella foenum graecum (Fenugreek), inhibits azoxymethane-induced aberrant crypt foci formation in F344 rats and induces apoptosis in HT-29 human colon cancer cells.
Raju J; Patlolla JM; Swamy MV; Rao CV
Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1392-8. PubMed ID: 15298963
[TBL] [Abstract][Full Text] [Related]
20. Dietary folate protects against azoxymethane-induced aberrant crypt foci development and oxidative stress in rat colon.
Al-Numair KS; Waly MI; Ali A; Essa MM; Farhat MF; Alsaif MA
Exp Biol Med (Maywood); 2011 Sep; 236(9):1005-11. PubMed ID: 21768165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
